Consider reading these articles
.webp)
Part 2: The Funding Surge and Founder Strategy
This is Part 2 of our three-part series on AI workforce solutions in healthcare. In Part 1, we explored the economic fundamentals driving the shift from IT budgets to labor budgets. Here, we examine the investor landscape and provide strategic guidance for founders building in this space.
A Growing Wave: The Funding Surge
From an investor lens, the agentic AI movement in healthcare is shifting from fringe to inevitability. This change has been driven not only by improvements in AI models but also by a growing understanding that workforce replacement is where the bulk of healthcare spending—and venture-scale returns—lies.
Specialization remains a defensible wedge. Investors are leaning into startups that tackle narrow, high-frequency pain points—such as prior authorization or surgical coordination—where incumbents offer limited depth. What matters now is time-to-impact. The best opportunities are those where AI can deliver an ROI within the first 90 days of deployment, either via labor replacement, denied claims avoided, or throughput gains. Capital is pursuing solutions that combine high automation with a clear go-to-market path, often targeting departmental Profit and Loss (P&L) Statements rather than enterprise IT.
The surge in funding for "AI labor" categories over the past 12 months is a clear signal. While some capital is flowing to platform plays, most investor interest is centered around automation-first companies with measurable outcomes—faster collections, fewer full-time employees (FTEs), and higher patient throughput—not "AI for AI's sake." One investor described it succinctly:
"If the AI agent doesn't show up on the staffing model or the P&L, it's not agentic—it's just software."
What's emerging is a market with increasing clarity. Incumbents are validating the need for automation, but it may take quarters to execute. Startups that can operate as workflow overlays, prove their case quickly, and partner where needed are best positioned to win. Expect the next wave of investor interest to flow not just into new AI models but also into distribution-layer startups—those that know how to slot agentic AI directly into budgeted labor problems and make the ROI undeniable.
In essence, we're seeing a gold rush of startups targeting every repetitive task in healthcare with AI, backed by serious capital. While incumbents are also adding AI capabilities, the market is vast enough for specialized solutions. This underscores that "AI workforce" solutions are not a fad; they represent a fundamental shift in how healthcare thinks about automation. The key for founders is executing smart go-to-market and scaling strategies, which we turn to next.
Founder Playbook: GTM Strategy, ROI Framing, and Navigating Regulation
For founders building agentic AI solutions in healthcare, success will hinge not just on the technology but also on how you take it to market and operate within the contours of healthcare. Here are some strategic considerations:
1. Target the Right Buyer and Pain Point
As stressed earlier, framing is everything. Identify the budget owner who feels the pain of the problem you're solving. If you have an AI that automates insurance verification, for instance, sell to the VP of Revenue Cycle or the COO, highlighting how it alleviates staffing shortages or cuts manual work – not just to the CIO as an IT efficiency tool. Many of the most successful deployments start in a specific department with a champion who needed to solve a labor challenge. Whether it's the call center director, the chief nursing officer, or the clinic manager, find that operational champion rather than relying solely on the IT steering committee. Aim to be categorized as "workforce augmentation" in the budget – this often gives you more runway to prove value than a tight IT line item.
The key is identifying processes ripe for automation. As one industry expert noted,
"The biggest opportunity lies within operational burdens in healthcare clinics, where processes like referral intake and prior authorization are methodical, require minimal clinical oversight, and have all necessary information readily available—there is no reason it should not be automated. Those are wide open for agentic AI automation."
2. Lead with ROI, Backed by Data
Healthcare executives are increasingly data-driven, and nothing opens doors faster than a clear ROI story. Since agentic AI solutions lend themselves to productivity metrics, build a compelling case early. For example: "Our pilot site saw a 30% reduction in nurse overtime hours within 3 months" or "Using our AI, billing staff were able to increase claims processed per day from 50 to 150, yielding an annualized $XM in cost savings." Having such numbers (even if from a small sample) helps overcome the skepticism that often greets new tech. Wherever possible, tie your value to revenue or hard dollars – cost savings, additional patients seen, reduced outsourced spending, improved payer reimbursements, etc. Soft metrics (such as patient satisfaction or clinician happiness) are nice but usually not sufficient alone to secure a budget. One pragmatic move is to structure contracts with a pilot phase and clear success criteria; if you hit the targets (e.g., cutting average call handling time by 20%), the rollout and budget expansion become no-brainers. Essentially, let the results sell for you after that initial foot in the door.
3. Avoid the Regulatory Quagmire (When Possible)
The FDA's regulation of software as a Medical Device (SaMD) can be a multi-year process, introducing significant overhead. A savvy strategy many AI startups use is to stay just outside the boundary of regulated clinical decision-making. That means focusing on use cases such as administrative workflow, patient communication, and care coordination rather than diagnostics or treatment recommendations. Many successful AI startups deliberately focus on "non-diagnostic" tasks to avoid the requirements of FDA clearance. Similarly, an AI that writes draft clinical notes for a doctor or triages appointment requests is generally not practicing medicine by itself and can be deployed without regulatory approval. Founders should have a deep understanding of the definitions. If your tool provides information for clinicians to consider (decision support) versus making autonomous clinical decisions, the regulatory implications differ in cases where some FDA oversight is inevitable (such as analyzing medical images for insights); factor that into your timeline and capital needs. However, if there's a path to deliver value in an unregulated way, that's often the wiser initial route. Also, keep an eye on evolving guidance; regulators are paying attention to AI, and staying on the right side of compliance (privacy, security, and any emerging AI-specific rules) is critical for long-term viability.
4. Build Moats Through Workflow Integration and Data
In the agentic AI arena, moats are created by embedding deeply into customer workflows and learning from data. The more your solution becomes a part of daily routine, the harder it is to remove. For example, suppose your AI schedules appointments autonomously and, over time, integrates with all the quirks of a clinic's scheduling rules and patient preferences. In that case, it becomes the de facto scheduler that staff rely on. Replacing it with a generic tool would cause disruption. Integration with EHRs, call systems, and other infrastructure can be a moat (albeit one that requires effort – but once done, you have an edge). Data feedback loops are another moat: every interaction your AI has (every call analyzed, every care plan generated) can make it smarter in domain-specific ways. Over time, you may accumulate the largest dataset of, for example, home health intake forms and outcomes. That proprietary data can improve your models beyond what a newcomer or a generic, large model could achieve, yielding better results and accuracy – which customers will care about. Moreover, incorporating clinician or user feedback to refine the AI's actions builds trust and efficacy. This is a "soft" moat, but in healthcare, trust is paramount; if your product is known to be safe and effective because it has been refined in the field, that reputation itself is a valuable asset. Finally, consider network effects or scale advantages: if your AI agent connects to, say, a network of providers and payers (imagine an AI that coordinates across organizations), having many participants makes it more valuable – an incumbent can't easily replicate that network overnight.
.png)
5. Mind the Change Management
One pragmatic note – even the best AI workforce solution will fail if end-users don't adopt it. Replacing or augmenting humans can provoke resistance (fear of job loss, distrust of AI decisions, etc.). Founders need a plan for change management: make the AI a tool that enhances the human worker's life, not a threat. In practice, this can mean starting in "assistant" mode (a co-pilot that the human can review or override) so that staff feel in control. It means providing training and a smooth user experience, so using the AI isn't more hassle than the old way. It means identifying internal champions at the client who will advocate for the AI and help get buy-in from peers. This is the less glamorous but vital part of GTM in healthcare – navigating human factors and organizational culture. Often, positioning the AI as taking away the "boring, tedious tasks" and freeing humans for higher-value work is a message that can win people over.
Additionally, if your economic buyer (such as a COO) is pushing for it due to ROI, ensure that you also win the hearts of the actual users (nurses, agents, etc.) by demonstrating how it reduces their burnout or workload. In the long run, agentic AI will not replace all healthcare jobs, but it will change the nature of employment – those who use it will find their roles evolving. Founders should be transparent about this and work to ensure that their product is viewed as a benefit, not a threat, by those on the front lines.
In Part 3 of this series, we'll examine the long-term implications of this AI workforce revolution—who ultimately captures value, how different stakeholders benefit, and what this means for the future of healthcare cost structures.
DATA INSIGHTS
Return to insights
.png){kind=spacer}
